Endovascular Treatment or Standard Medical Care for Cerebral Venous Sinus Thrombosis(ESCORT)

NARecruitingINTERVENTIONAL
Enrollment

224

Participants

Timeline

Start Date

August 9, 2024

Primary Completion Date

January 31, 2029

Study Completion Date

August 31, 2029

Conditions
Cerebral Venous Sinus Thrombosis
Interventions
DRUG

Heparin

The patients randomized to standard medical care will receive (or continue) either any type of body-weight adjusted low molecular weight heparin in therapeutic dose, or intravenous adjusted dose unfractionated heparin (aPTT value kept within 1 time the normal value), according to the existing international guidelines.

PROCEDURE

Endovascular treatment

Standard endovascular techniques to mechanically remove clot material, such as mechanical thrombectomy and/or balloon angioplasty and/or local application of alteplase or urokinase within the thrombosed sinuses.

Trial Locations (1)

100010

RECRUITING

Beijing Tiantan Hospital, Beijing

All Listed Sponsors
lead

Beijing Tiantan Hospital

OTHER